Skip to main content

Table 1 Baseline Characteristics

From: Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema

 

CPFE (n = 85)

IPF (n = 112)

P value

Age (year)

66.4 (6.7)

66.7 (6.2)

0.72

Gender (F)

13 (15.29%)

31 (27.68%)

0.039

Ethnicity

  

0.225

Caucasian

75 (88%)

98 (87.5%)

 

Hispanic

1 (1.2%)

6 (5.36%)

 

African American

9 (10.6%

8 (7.14%)

 

Prior History of Smoking

85 (100%)

66 (58.9%)

< 0.01

Pack-years

42.47 (20.2)

22.2 (11)

< 0.01

BMI (kg/m2)

29.4 (4.5)

27.9 (4.4)

0.02

FVC (L)

2.73 (0.79)

1.75 (0.55)

< 0.01

FVC %

69.2 (18.1)

45.6 (11.7)

< 0.01

FEV1 (L)

2.04 (0.6)

1.48 (0.46)

< 0.01

FEV1%

69.6 (22.5)

51.8 (13.8)

< 0.01

FEV1/FVC

74.0 (12.84)

84.54 (7.27)

< 0.01

TLC (L)

4.17 (1.2)

2.89 (0.7)

< 0.01

TLC %

66.1 (16.5)

47.17 (8.6)

< 0.01

RV (L)

1.4 (0.61)

0.93 (0.32)

< 0.01

RV (%)

59.24 (29.6)

41.63 (13.4)

< 0.01

RV/TLC

32.8 (7.3)

32.1 (9.0)

0.61

DLCO %

21.5 (8.2)

27.1 (11.5)

< 0.01

DLCO/VA %

39.34 (14.4)

57.14 (17.6)

< 0.01

PaO2 (mmHg)

55.9 (12.9)

54.78 (11.6)

0.53

PCO2 (mmHg)

37.23 (6.0)

39.81 (5.9)

0.04

O2 at rest (LPM)

3.14 (2.5)

3.23 (2.5)

0.79

O2 on exertion (LPM)

13.0 (3.6)

10.3 (3.9)

0.033

6-MWTD (meters)

260.2 (86.7)

260 (82)

0.98

LVEF (%)

61.5 (6.6)

62.2 (6.7)

0.47

Pulmonary HTN (%)

38 (44.7%)

33 (29.5%)

0.027

mPAP (mmHg)

28.43 (10.8)

23.5 (9.1)

< 0.01

PCWP (mmHg)

9.84 (5.5)

7.95 (4.8)

0.011

PVR (Wood units)

4.3 (3.2)

3.37 (2.1)

0.016